Welcome to our dedicated page for Health Catalyst news (Ticker: HCAT), a resource for investors and traders seeking the latest updates and insights on Health Catalyst stock.
Health Catalyst, Inc. (Nasdaq: HCAT) is a provider of data and analytics technology and services for healthcare organizations, and its news flow reflects this focus on data-informed healthcare improvement. Company announcements frequently highlight developments in its cloud-based technology ecosystem, Health Catalyst Ignite™, AI-enabled analytics solutions, and expert services that support measurable clinical, financial, and operational outcomes.
Investors and healthcare professionals following HCAT news will see regular earnings releases and financial updates, including quarterly results, segment performance for Technology and Professional Services, and guidance on total revenue and adjusted EBITDA. These releases are often accompanied by conference call details and references to key risk factors discussed in the company’s SEC filings.
Health Catalyst news also covers client partnerships and platform deployments. Recent examples include UnityPoint Health’s migration from a legacy Health Catalyst data platform to the modern Ignite Data and Analytics platform, and CyncHealth Nebraska’s expanded partnership using the company’s Ninja Universe technology to improve Continuity of Care Documents across a statewide health information exchange.
Another recurring theme in HCAT news is security and compliance milestones. The company has announced HITRUST r2 Certification for offerings such as Twistle, Lumeon, and Upfront, underscoring its focus on information protection for healthcare data. Governance and leadership updates, including the appointment of a President and Chief Operating Officer, board additions, and the planned retirement of the CEO, are disclosed through press releases and 8-K filings.
Visitors to this HCAT news page can review these announcements in one place, from investor conference participation and Catalyst Awards recognition of client achievements to regulatory and corporate governance updates, providing a consolidated view of Health Catalyst’s ongoing activities in healthcare data and analytics.
Health Catalyst (Nasdaq: HCAT), a leading provider of data and analytics technology for healthcare organizations, has announced its plans to release second quarter 2024 operating results on Wednesday, August 7, 2024, after market close. The company will host a conference call at 5 p.m. E.T. on the same day to review the results.
Participants can join the call by dialing 800-267-6316 (U.S.) or 203-518-9783 (international) with the conference ID "HCATQ224". A live audio webcast will be available at https://ir.healthcatalyst.com/, with a replay accessible shortly after the call for approximately 90 days.
Health Catalyst (Nasdaq: HCAT) has secured a $225 million credit facility with Silver Point Finance. The facility includes an initial $125 million term loan and a $100 million delayed draw option. The company will use the funds to refinance existing convertible notes due in 2025 and support its growth strategy.
CEO Dan Burton emphasized the importance of this non-dilutive capital for pursuing organic and inorganic growth opportunities. CFO Jason Alger highlighted the flexibility of the financing structure, allowing Health Catalyst to address near-term debt maturity while focusing on creating shareholder value and maintaining a strong balance sheet.
Health Catalyst (Nasdaq: HCAT) has completed its acquisition of Carevive Systems, a health technology company specializing in oncology. Carevive's platform is used for treatment care planning, clinical trial screening, care coordination, remote patient monitoring, and post-treatment care. This acquisition will enhance Health Catalyst's capabilities in oncology care and patient-reported outcomes. Both companies aim to leverage data and analytics to improve patient care and outcomes. The integration promises to deliver innovative solutions to cancer centers and provide researchers with valuable real-world data.
Health Catalyst (Nasdaq: HCAT), a top provider of data and analytics technology in healthcare, announced its participation in key investor conferences. CFO Jason Alger and VP of Investor Relations Jack Knight will represent the company.
They will attend The Stifel Cross Sector Insight Conference in Boston, featuring a fireside chat on June 4, 2024, at 9:45am ET. Additionally, they will present at The Goldman Sachs 45th Annual Global Healthcare Conference in Miami, scheduled for June 12, 2024, at 8:40am ET.
Health Catalyst (Nasdaq: HCAT) has launched Health Catalyst Ignite®, a next-generation data and analytics ecosystem designed for the healthcare sector. The platform integrates advanced technologies, healthcare-specific data models, self-service tools, and industry expertise to address the challenges of data management in healthcare. Ignite offers seamless integration, scalability, and flexibility, reducing costs and improving decision-making. It enables data sharing, centralizes data governance, and democratizes analytics to provide faster insights and enhanced control. The platform supports a range of healthcare use cases, from clinical improvement to operational efficiency, leveraging AI and machine learning for predictive insights.
Health Catalyst, Inc. reported strong financial results for the first quarter of 2024, with total revenue of $74.7 million and Adjusted EBITDA of $3.4 million, beating guidance mid-points. The company remains focused on long-term profitability goals and reaffirmed its full-year guidance for 2024. Key metrics show growth in gross profit and margins, with a 1% increase in total revenue year over year. However, there was a 19% decrease in Adjusted EBITDA compared to the same period last year.
Summary not available.
Summary not available.
Summary not available.
Summary not available.